Sponsor or institution
Clinical trials and research at Curis, Inc.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Curis, Inc. that are recruiting, at sites in 7 countries (most in Italy (2), Spain (2), United States (2)). By phase: Phase 1/2 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 7Countries
All recruiting trials (2)
-
Emavusertib plus zanubrutinib for CLL and other B‑cell cancers
This test will see if adding emavusertib to the BTK inhibitor zanubrutinib can reduce measurable residual disease in adults with chronic lymphocytic leukemia or other B‑cell malignancies.
-
Evaluating Emavusertib for Relapsed or Refractory Primary Central Nervous System Lymphoma
This study is testing a new drug called emavusertib, alone and with another medication, to see if it can help adults with tough-to-treat primary central nervous system lymphoma feel better.
Quick answers
How many clinical trials run by Curis, Inc. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 7 countries. The most sites are in Italy (2 trials), Spain (2 trials), United States (2 trials), Czechia (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.